Cited by 22Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

A real-time continuous glucose monitoring-based algorithm to trigger hypotreatments to prevent/mitigate hypoglycemic events

Camerlingo, Nunzio, Vettoretti, Martina, Del Favero, Simone, Cappon, Giacomo, Sparacino, Giovanni, Facchinetti, Andrea·2019·Diabetes Technology & Therapeutics

Abstract

Background: The standard treatment for hypoglycemia recommended by the American Diabetes Association (ADA) suggests patients with diabetes to take small amounts of carbohydrates, the so-called hypotreatments (HTs), as soon as blood glucose concentration goes below 70 mg/dL. However, prevention, or at least mitigation, of hypoglycemic events could be achieved by triggering HTs ahead of time thanks to the use of the predictive capabilities of suitable real-time algorithms fed by continuous glucose monitoring (CGM) sensor data. Materials and Methods: The algorithm proposed in this article to trigger HTs for preventing forthcoming hypoglycemic events is based on the computation of the “dynamic risk”, there is a nonlinear function combining current glycemia with its rate-of-change, both provided by CGM. A comparison of performance of the proposed algorithm against the ADA guidelines is made, in silico , on datasets of 100 virtual patients undergoing a single-meal experiment, with induced postmeal hypoglycemia, generated by the UVA/Padova type 1 diabetes simulator. Results: On noise-free CGM data, the proposed algorithm reduces the time spent in hypoglycemia, on median [25th–75th percentiles] from 36 [29–43] to 0 [0–11] min ( P < 0.0001), with a concomitant decrease of the post-treatment rebound (PTR) in glucose concentration, on median [25th–75th percentiles] from 136 [121–148] to 121 [116–127] mg/dL ( P < 0.0001). On noisy CGM data, there is still a reduction of both time spent in hypoglycemia from 41 [28–49] min to 25 [0–41] min ( P < 0.0001) and PTR from 174 [146–189] mg/dL to 137 [123–151] mg/dL ( P < 0.0001). Conclusions: The potentiality of the new algorithm in generating preventive HTs, which can allow significant reduction of hypoglycemia without concomitant increase of hyperglycemia, suggests its further development and test in silico, for example, simulating both insulin pump and multiple-daily-injection therapies.

Integrity signals

Registry

Crossref · 10.1089/dia.2019.0139

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • If provided sufficiently in advance, predictive alerts allow the patient to take suitable countermeasures, such as preventive hypo-treatments or correction boluses, to mitigate or even prevent critical episodes.

    “If provided sufficiently in advance, predictive alerts allow the patient to take suitable countermeasures, e.g., preventive hypo-treatments or correction boluses, to mitigate, or even prevent, such critical episodes [50].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Camerlingo, N., Vettoretti, M., Del Favero, S., Cappon, G., Sparacino, G., & Facchinetti, A.
Affiliations
  • University of Padua (IT)
  • Department of Information Engineering, University of Padova, Padova, Italy.
Corresponding author
Facchinetti, Andrea
Venue
Diabetes Technology & Therapeutics
Published
2019-10-21
Volume
21
Issue
11
Pages
644-655
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2963798798
Cited by
22
References
30
Citations by year
2025: 2 · 2024: 2 · 2023: 8 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 1
FWCI
2.03
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
hypoglycemia prevention, continuous glucose monitoring, real-time algorithms, dynamic risk, type 1 diabetes, postprandial hypoglycemia, UVA/Padova simulator, sensor noise robustness, insulin pump, multiple daily insulin injections
MeSH terms
Algorithms, Blood Glucose, Computer Simulation, Diabetes Mellitus, Type 1, Dietary Carbohydrates, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Retrospective Studies, Blood Glucose Self-Monitoring, Reproducibility of Results, Biosensing Techniques, Postprandial Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review